Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline Cognition.

Duff K, Hammers DB, Dalley BCA, Suhrie KR, Atkinson TJ, Rasmussen KM, Horn KP, Beardmore BE, Burrell LD, Foster NL, Hoffman JM.

J Prev Alzheimers Dis. 2017;4(2):87-92. doi: 10.14283/jpad.2017.9.

2.

Do people use category-learning judgments to regulate their learning of natural categories?

Morehead K, Dunlosky J, Foster NL.

Mem Cognit. 2017 Nov;45(8):1253-1269. doi: 10.3758/s13421-017-0729-9.

PMID:
28707177
3.

The impact of β-amyloid positron emission tomography on the diagnostic and treatment decisions of dementia experts.

Ganz ML, Tawah AF, Guo S, Chitnis AS, Silies H, Schäuble B, Jovalekic A, Foster NL.

Neurodegener Dis Manag. 2017 Apr;7(2):107-117. doi: 10.2217/nmt-2016-0059. Epub 2017 Apr 26.

PMID:
28445082
4.

Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults.

Hammers DB, Atkinson TJ, Dalley BC, Suhrie KR, Beardmore BE, Burrell LD, Horn KP, Rasmussen KM, Foster NL, Duff K, Hoffman JM.

Clin Neuropsychol. 2017 Apr;31(3):531-543. doi: 10.1080/13854046.2016.1278039. Epub 2017 Jan 12.

5.

Symbiodinium biogeography tracks environmental patterns rather than host genetics in a key Caribbean reef-builder, Orbicella annularis.

Kennedy EV, Tonk L, Foster NL, Chollett I, Ortiz JC, Dove S, Hoegh-Guldberg O, Mumby PJ, Stevens JR.

Proc Biol Sci. 2016 Nov 16;283(1842). pii: 20161938.

6.

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.

Witte MM, Foster NL, Fleisher AS, Williams MM, Quaid K, Wasserman M, Hunt G, Roberts JS, Rabinovici GD, Levenson JL, Hake AM, Hunter CA, Van Campen LE, Pontecorvo MJ, Hochstetler HM, Tabas LB, Trzepacz PT.

Alzheimers Dement (Amst). 2015 Jul 26;1(3):358-67. doi: 10.1016/j.dadm.2015.06.006. eCollection 2015 Sep.

7.

Time-related expression profiles for heat shock protein gene transcripts (HSP40, HSP70) in the central nervous system of Lymnaea stagnalis exposed to thermal stress.

Foster NL, Lukowiak K, Henry TB.

Commun Integr Biol. 2015 Jun 22;8(3):e1040954. doi: 10.1080/19420889.2015.1040954. eCollection 2015 May-Jun.

8.

The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.

Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY.

Alzheimers Dement. 2015 Jul;11(7):757-71. doi: 10.1016/j.jalz.2015.05.001. Review.

9.

Short-Term Practice Effects and Brain Hypometabolism: Preliminary Data from an FDG PET Study.

Duff K, Horn KP, Foster NL, Hoffman JM.

Arch Clin Neuropsychol. 2015 May;30(3):264-70. doi: 10.1093/arclin/acv018.

10.

Adiponectin and Insulin in Gray Seals during Suckling and Fasting: Relationship with Nutritional State and Body Mass during Nursing in Mothers and Pups.

Bennett KA, Hughes J, Stamatas S, Brand S, Foster NL, Moss SE, Pomeroy PP.

Physiol Biochem Zool. 2015 May-Jun;88(3):295-310. doi: 10.1086/680862. Epub 2015 Mar 4.

PMID:
25860828
11.

Status of management effort in 153 marine protected areas across the English Channel.

Rodríguez-Rodríguez D, Sciberras M, Foster NL, Attrill MJ.

Mar Pollut Bull. 2015 May 15;94(1-2):168-75. doi: 10.1016/j.marpolbul.2015.02.036. Epub 2015 Mar 29.

PMID:
25825075
12.

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.

Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C Jr, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative Investigators.

JAMA Neurol. 2015 May;72(5):571-81. doi: 10.1001/jamaneurol.2014.4829.

13.

Perceptions of tissue storage in a dementia population among spouses and offspring.

Martin MM, Rothwell EW, Venne VL, Foster NL.

J Genet Couns. 2015 Jun;24(3):503-11. doi: 10.1007/s10897-015-9818-8. Epub 2015 Feb 3.

PMID:
25641253
14.

The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data.

Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, Margolin R, Landau S, Foster NL, Mason NS, De Santi S, Suhy J, Koeppe RA, Jagust W; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Sep;11(9):1050-68. doi: 10.1016/j.jalz.2014.09.004. Epub 2014 Nov 24. Review.

15.

Factors associated with cognitive evaluations in the United States.

Kotagal V, Langa KM, Plassman BL, Fisher GG, Giordani BJ, Wallace RB, Burke JR, Steffens DC, Kabeto M, Albin RL, Foster NL.

Neurology. 2015 Jan 6;84(1):64-71. doi: 10.1212/WNL.0000000000001096. Epub 2014 Nov 26.

16.

Excitatory and inhibitory projections in parallel pathways from the inferior colliculus to the auditory thalamus.

Mellott JG, Foster NL, Ohl AP, Schofield BR.

Front Neuroanat. 2014 Nov 5;8:124. doi: 10.3389/fnana.2014.00124. eCollection 2014.

17.

Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system.

Puig KL, Lutz BM, Urquhart SA, Rebel AA, Zhou X, Manocha GD, Sens M, Tuteja AK, Foster NL, Combs CK.

J Alzheimers Dis. 2015;44(4):1263-78. doi: 10.3233/JAD-142259.

PMID:
25408221
18.

Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence.

Foster NL, Hackett JSM, White G, Chenevert S, Svarvar P, Bain L, Carrillo MC.

Alzheimers Dement. 2014 Jul;10(4):503-508. doi: 10.1016/j.jalz.2014.05.003.

PMID:
24985689
19.

Distribution of GABAergic cells in the inferior colliculus that project to the thalamus.

Mellott JG, Foster NL, Nakamoto KT, Motts SD, Schofield BR.

Front Neuroanat. 2014 Mar 31;8:17. doi: 10.3389/fnana.2014.00017. eCollection 2014.

20.

Relationship of hearing loss and dementia: a prospective, population-based study.

Gurgel RK, Ward PD, Schwartz S, Norton MC, Foster NL, Tschanz JT.

Otol Neurotol. 2014 Jun;35(5):775-81. doi: 10.1097/MAO.0000000000000313.

21.

Projections from the dorsal and ventral cochlear nuclei to the medial geniculate body.

Schofield BR, Motts SD, Mellott JG, Foster NL.

Front Neuroanat. 2014 Mar 5;8:10. doi: 10.3389/fnana.2014.00010. eCollection 2014.

22.

Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.

Duff K, Foster NL, Hoffman JM.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):247-52. doi: 10.1097/WAD.0000000000000021.

23.

Coverage with evidence development: what to consider.

Foster NL, Mottola K, Hoffman JM.

JAMA Neurol. 2014 Apr;71(4):399-400. doi: 10.1001/jamaneurol.2013.5812. Review. No abstract available.

PMID:
24492892
24.

Familial strife on the seashore: aggression increases with relatedness in the sea anemone Actinia equina.

Foster NL, Briffa M.

Behav Processes. 2014 Mar;103:243-5. doi: 10.1016/j.beproc.2014.01.009. Epub 2014 Jan 22.

PMID:
24463009
25.

Perineuronal nets and GABAergic cells in the inferior colliculus of guinea pigs.

Foster NL, Mellott JG, Schofield BR.

Front Neuroanat. 2014 Jan 8;7:53. doi: 10.3389/fnana.2013.00053. eCollection 2014.

26.

Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study.

Kauwe JS, Ridge PG, Foster NL, Cannon-Albright LA.

PLoS One. 2013 Oct 8;8(10):e77087. doi: 10.1371/journal.pone.0077087. eCollection 2013.

27.

Amyloid deposition and cognition in older adults: the effects of premorbid intellect.

Duff K, Foster NL, Dennett K, Hammers DB, Zollinger LV, Christian PE, Butterfield RI, Beardmore BE, Wang AY, Morton KA, Hoffman JM.

Arch Clin Neuropsychol. 2013 Nov;28(7):665-71. doi: 10.1093/arclin/act047. Epub 2013 Jun 30.

28.

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM; Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Alzheimers Dement. 2013 Jul;9(4):e106-9. doi: 10.1016/j.jalz.2013.06.001.

PMID:
23809369
29.

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM.

J Nucl Med. 2013 Jul;54(7):1011-3. doi: 10.2967/jnumed.113.127068. Epub 2013 Jun 10.

30.

Using species-area relationships to inform baseline conservation targets for the deep North East Atlantic.

Foster NL, Foggo A, Howell KL.

PLoS One. 2013;8(3):e58941. doi: 10.1371/journal.pone.0058941. Epub 2013 Mar 20.

31.

A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations.

Foster NL, Jagust WJ, Fox NC.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):1-3. doi: 10.1097/WAD.0b013e31828ab5d8. No abstract available.

PMID:
23411640
32.

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH; Alzheimer's Association; Society of Nuclear Medicine and Molecular Imaging; Amyloid Imaging Taskforce.

Alzheimers Dement. 2013 Jan;9(1):e-1-16.

33.

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH.

J Nucl Med. 2013 Mar;54(3):476-90. doi: 10.2967/jnumed.113.120618. Epub 2013 Jan 28. Review.

34.

Hurricane-driven patterns of clonality in an ecosystem engineer: the Caribbean coral Montastraea annularis.

Foster NL, Baums IB, Sanchez JA, Paris CB, Chollett I, Agudelo CL, Vermeij MJ, Mumby PJ.

PLoS One. 2013;8(1):e53283. doi: 10.1371/journal.pone.0053283. Epub 2013 Jan 7.

35.

Metacognition influences item-method directed forgetting.

Foster NL, Sahakyan L.

J Exp Psychol Learn Mem Cogn. 2012 Sep;38(5):1309-24. doi: 10.1037/a0027868. Epub 2012 Apr 2.

PMID:
22468801
36.

Connectivity of Caribbean coral populations: complementary insights from empirical and modelled gene flow.

Foster NL, Paris CB, Kool JT, Baums IB, Stevens JR, Sanchez JA, Bastidas C, Agudelo C, Bush P, Day O, Ferrari R, Gonzalez P, Gore S, Guppy R, McCartney MA, McCoy C, Mendes J, Srinivasan A, Steiner S, Vermeij MJ, Weil E, Mumby PJ.

Mol Ecol. 2012 Mar;21(5):1143-57. doi: 10.1111/j.1365-294X.2012.05455.x. Epub 2012 Jan 25.

PMID:
22276913
37.

Neurology Academic Advisory Committee: a strategy for faculty retention and advancement.

Schenkenberg T, Foster NL, Bromberg MB, DeWitt LD, Flanigan KM.

Neurology. 2011 Aug 16;77(7):684-90. doi: 10.1212/WNL.0b013e318229e67a. Epub 2011 Jul 27.

PMID:
21795659
38.

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.

Jack CR Jr, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL.

Alzheimers Dement. 2011 Jul;7(4):474-485.e4. doi: 10.1016/j.jalz.2011.04.007.

39.

Incidence of dementia and cognitive impairment, not dementia in the United States.

Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, Burke JR, Steffens DC, Foster NL, Giordani B, Unverzagt FW, Welsh-Bohmer KA, Heeringa SG, Weir DR, Wallace RB.

Ann Neurol. 2011 Sep;70(3):418-26. doi: 10.1002/ana.22362. Epub 2011 Mar 18.

40.

Characterizing Alzheimer's disease using a hypometabolic convergence index.

Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 1;56(1):52-60. doi: 10.1016/j.neuroimage.2011.01.049. Epub 2011 Jan 27.

41.

The role of forget-cue salience in list-method directed forgetting.

Foster NL, Sahakyan L.

Memory. 2011 Jan;19(1):110-7. doi: 10.1080/09658211.2010.537665.

PMID:
21240753
42.

Validation of consensus panel diagnosis in dementia.

Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY.

Arch Neurol. 2010 Dec;67(12):1506-12. doi: 10.1001/archneurol.2010.301.

43.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL.

Arch Neurol. 2011 Mar;68(3):329-37. doi: 10.1001/archneurol.2010.295. Epub 2010 Nov 8.

44.

Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.

Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2010 Oct 15;192(2):277-85. doi: 10.1016/j.jneumeth.2010.07.030. Epub 2010 Aug 1.

45.

Comparing predictors of conversion and decline in mild cognitive impairment.

Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30.

46.

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):221-9. doi: 10.1016/j.jalz.2010.03.003.

47.

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.

Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Jun;51(2):654-64. doi: 10.1016/j.neuroimage.2010.02.064. Epub 2010 Mar 2.

48.

Relationships between biomarkers in aging and dementia.

Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Oct 13;73(15):1193-9. doi: 10.1212/WNL.0b013e3181bc010c.

49.

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5.

50.

The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC.

Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101. doi: 10.1097/WAD.0b013e318191c7dd. Review.

Supplemental Content

Loading ...
Support Center